✦ LIBER ✦

Cost-effectiveness of fluticasone propionate/salmeterol (500/50 μg) in the treatment of COPD

✍ Scribed by Stephanie R. Earnshaw; Michele R. Wilson; Anand A. Dalal; Mike G. Chambers; Priti Jhingran; Richard Stanford; Douglas W. Mapel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of fluticasone propionate/salmete

✍ Gary T. Ferguson; Antonio Anzueto; Richard Fei; Amanda Emmett; Katharine Knobil; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 355 KB

PRS6 COST-EFFECTIVENESS OF FLUTICASONE P

✍ Bueno, RLP; Godoy, MR 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

Initiation of maintenance treatment with

✍ N.C. Barnes; L. Jacques; C. Goldfrad; E.D. Bateman 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 342 KB

Cost-effectiveness of salmeterol/flutica

✍ B. LUNDBÄCK; C. JENKINS; M.J. PRICE; R.M.A. THWAITES 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 212 KB

Steroid-sparing effects of fluticasone p

✍ Busse, William; Koenig, Steven M.; Oppenheimer, John; Sahn, Steven A.; Yancey, S 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Cost-effectiveness analysis of fluticaso

✍ Leibman, Christopher; Pathak, Dev; Bowers, Brian; Dorinsky, Paul M; Pepsin, Pame 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 141 KB

Cost-effectiveness of fluticasone propionate/salmeterol (500/50&#xa0;μg) in the treatment of COPD